Bluejay Diagnostics, Inc. — Form 10-Q
Filed August 12, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
Neil Dey, serving as both President/CEO and Principal Financial Officer, certified the Q2 2026 10-Q filed August 12, 2026. He attested that disclosure controls and internal controls over financial reporting are effective, financial statements fairly present the company's condition, and no material weaknesses or fraud were identified. This is standard boilerplate certification with no specific operational, financial, or strategic changes disclosed.
Why this rating
Routine SOX 302/906 certification. No disclosed control deficiencies, fraud, or accounting changes. Administrative document; no business impact.
See more from August 12, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.